HSA — authorised 27 April 1955
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇸🇬 Solu-Cortef in Singapore
HSA authorised Solu-Cortef on 27 April 1955
Marketing authorisation
Solu-Cortef in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Solu-Cortef approved in Singapore?
Yes. HSA authorised it on 27 April 1955.
Who is the marketing authorisation holder for Solu-Cortef in Singapore?
PHARMACIA AND UPJOHN holds the Singaporean marketing authorisation.